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P2X7 receptorWe have previously described that arachidonic acid (AA)-5-lipoxygenase (5-LO) metabolism inhibitors such as
NDGA andMK886, inhibit cell death by apoptosis, but not by necrosis, induced by extracellular ATP (ATPe) bind-
ing to P2X7 receptors inmacrophages. ATPe binding to P2X7 also induces large cationic and anionic organicmol-
ecules uptake in these cells, a process that involves at least two distinct transport mechanisms: one for cations
and another for anions. Here we show that inhibitors of the AA-5-LO pathway do not inhibit P2X7 receptors,
as judged by the maintenance of the ATPe-induced uptake of ﬂuorescent anionic dyes. In addition, we describe
two new transport phenomena induced by these inhibitors inmacrophages: a cation-selective uptake of ﬂuores-
cent dyes and the release of ATP. The cation uptake requires secreted ATPe, but, differently from the P2X7/ATPe-
induced phenomena, it is also present inmacrophages derived frommice deﬁcient in the P2X7 gene. Inhibitors of
phospholipase A2 and of the AA-cyclooxygenase pathway did not induce the cation uptake. The uptake of non-
organic cationswas investigated bymeasuring the free intracellular Ca2+ concentration ([Ca2+]i) by Fura-2 ﬂuo-
rescence. NDGA, but notMK886, induced an increase in [Ca2+]i. Chelating Ca
2+ ions in the extracellular medium
suppressed the intracellular Ca2+ signal without interfering in the uptake of cationic dyes. We conclude that in-
hibitors of the AA-5-LO pathway do not block P2X7 receptors, trigger the release of ATP, and induce an ATP-
dependent uptake of organic cations by a Ca2+- and P2X7-independent transport mechanism in macrophages.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Macrophages are multi-functional and highly plastic cells that dis-
play important roles in the immune-inﬂammatory system and in the
homeostasis ofmammalian tissue [39,45,50,85]. Macrophage activation
is a tightly controlled event, regulated by the production and secretion
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i).diversiﬁed panel of receptors and transport systems in their plasma
membrane that may change according to their speciﬁc differentiation
state and microenvironment milieu [25,84]. Lipid metabolism has
been a major focus of attention in the study of macrophages due to its
involvement in intracellular signaling, production of eicosanoids, ath-
erosclerosis, and obesity, among others. In this regard, inhibitors of
lipoxygenase (LO) and cyclooxygenase (Cox) are widely used to study
the arachidonic acid (AA) metabolism [20,42,72] although their effect
on ion channels and other transport mechanism has not been so well
investigated.
Among the several ion channels and other transport mechanisms
displayed on macrophage membranes, the ones related to extracellular
purine and pyrimidine nucleotides have gained attention in recent
years [6,9,53]. Extracellular ATP (ATPe) and other nucleotides can bind
one or more of the nucleotide receptors (P2 receptors) expressed in
macrophage plasma membrane and other cells of the immune system
[3,6,16,22,23,31,40,43,64] as well as inducing the secretion of cytokines
[22,27,30,64] and the production of reactive oxygen species (ROS) [16,
1968 H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–197733,81]. The activation of phospholipases A2 (PLA2), the release of AA,
and the synthesis and secretion of bioactive eicosanoids have also
been reported [4,52,82].
More speciﬁcally, the P2X7 receptor is an ATPe-gated cation-
selective channel (Na+, K+, and Ca2+) that is connected with an intra-
cellular array of signaling pathways [15,21,26,44] and is well known for
its involvement in the activation of inﬂammasome and secretion of IL1-
β [24,27,30,32,37,58]. It can also induce macrophage death by necrosis
and apoptosis [14,17,35,41,48,49,51]. Its discovery and initial character-
ization were related to the phenomenon known as ATPe-induced
permeabilization of the plasma membrane, characterized by the fast
(1–20 min) uptake of ﬂuorescent dyes such as the cation ethidium
and the anion Lucifer yellow [18,60,74,77]. The uptake of these large
ﬂuorescent organic molecules is the result of a complex transport mech-
anism coupled to the P2X7 receptor through a poorly understood signal-
ing pathway and involves at least two distinct transportmechanisms, one
for cations and another one for anions [11,47,71].
We have previously described the involvement of AA-5-LOmetabo-
lism in the ATPe-induced P2X7-dependent apoptosis of macrophages
[14]. Mepacrine, a generic inhibitor of PLA2, 2-bromo-enol-lactone
(BEL) – an inhibitor of Ca2+-independent PLA2 (iPLA2), and the inhibi-
tors of AA-LO pathway nordihydroguaiaretic acid (NDGA) – a general
inhibitor of LOs, MK886 – an inhibitor of the 5-lipoxygenase-
activating protein (FLAP), and the selective inhibitors of 5-LO Zileuton,
and AA-861, but not the inhibitors of Cox, ASA and NS-398, inhibit apo-
ptosis. Noneof these drugs inhibits necrosis [14]. These results leadus to
propose that an iPLA2-5-LO pathway is activated by purinergic P2X7 re-
ceptors in macrophages in connection with the induction of apoptotic
cell death [14].
During the course of experiments aimed to investigate the involve-
ment of the AA pathways in other P2X7-associated phenomena, we
asked whether the inhibitors that blocks ATPe-induced apoptosis
could also modulate the ATPe-induced uptake of organic molecules.
While performing initial experiments,we observed that some inhibitors
of 5-LO induced a fast uptake of the cationic dye ethidium by macro-
phages in the absence of any exogenous addition of ATP. This unexpect-
ed result prompted us to investigate the effects of several anti-
inﬂammatory drugs and other inhibitors of AA pathways on the trans-
membrane transport of organic molecules on macrophages. Here we
describe the induction of ATP release and the characterization of a
P2X7-independent transport mechanism selective for organic cations,
induced by inhibitors of the AA-5-LO pathway, but not by inhibitors of
Cox, in intraperitoneal murine macrophages.
2. Materials and methods
2.1. Materials
DMEM, fetal bovine serum penicillin and streptomycinwere obtained
from Gibco/BRL (São Paulo, RJ, Brasil); 3-[1-(para-Chlorobenzyl)-5-
(isopropyl)-3-t-butylthioindol-2-yl]-2,2-dimethylpropanoic acid (MK886)
was from Calbiochem (San Diego, CA, USA); thioglycollate medium was
from Difco (Detroit, MI, USA). NaCl, MgCl2, CaCl2, and KCl were from
Reagen (Rio de Janeiro, RJ, Brazil); nordihydroguaiaretic acid (NDGA),
mepacrine, ATP, 2-bromo-enol-lactone (BEL), EGTA, HEPES, dimethyl
sulfoxide (DMSO), ethidium bromide (EB), Lucifer yellow (LY) lith-
ium salt, propidium iodide (PI), carboxyﬂuorescein (CF), ionomycin,
Zileuton, acetylsalicylic acid (ASA), N-[2-(Cyclohexyloxy)-4-nitro-
phenyl]methanesulfonamide (NS398), 2-(12-Hydroxydodeca-5,10-
diynyl)-3,5,6-trimethyl-p-benzoquinone (AA-861), probenecid,
luciferase, CoA, apyrase, brefeldin A, and phosphate buffered saline
(PBS), were purchased from Sigma-Aldrich (São Paulo, Brazil); YO-
PRO-1, TOPRO-2, TOTO-3, sulforhodamine B (SR-B), Fura-2AM, and
D-luciferin were from Life Technologies (São Paulo, Brazil). Most re-
agents were pre-diluted in a 1000× stock solution either in DMSO
(BEL, MK886, Zileuton, Fura-2, NDGA, AA-861, NS398, ionomycin,TOPRO-3, TOTO-3) or in the normal salt solution or Milli-Q® water
and kept frozen until use. NDGA was prepared fresh on the day of the
experiment. BEL stock solution was prepared in a concentration 100×
the highest used dose.
2.2. Animals
Swiss-Webster and C57/Bl6 mice were obtained from the animal fa-
cilities of the Instituto de Microbiologia Paulo de Goes and from the
Transgenic Animal Facility of the Instituto de Biofísica Carlos Chagas
Filho of the Federal University of Rio de Janeiro (LAT-UFRJ). Male mice
lacking the 5-LO enzyme gene (5-LO−/−) were obtained from The Jack-
son Laboratory, and age-matched male wild type (WT) mice (back-
ground, strain 129) were used as controls. P2X7−/− were obtained
from The Jackson Laboratory and bred at LAT-UFRJ. All animals were
eight to twelve weeks old, weighed approximately 16–30 g and were
handled according to the guidelines for animal use in scientiﬁc experi-
ments of the Instituto de Biofísica Carlos Chagas Filho of the Federal
University of Rio de Janeiro and the Animal Care Committee of the
Universidade Estadual de Campinas.
2.3. Macrophage isolation and culture
Thioglycollate-elicited macrophages were obtained from the intra-
peritoneal cavity of mice, collected 4 days after thioglycollate injection,
as previously described [18]. In brief, cells were washed in DMEM and
kept on ice at a concentration of 106 cells/mL until used (freshly isolated
macrophages) or plated on 35mmplastic culture dishes at a concentra-
tion of 2 × 105 cells/dish in 2 mL DMEM supplemented with 10% fetal
bovine serum, 2 g/L sodium bicarbonate, 0.3 mg/L L-glutamine,
100 U/mL penicillin, and 100 μg/mL streptomycin (complete medium)
at 37 °C in a humidiﬁed atmosphere containing 5% CO2. Non-
adherent cells were then removed after 1 h and the macrophages
were kept for 2–5 days under the same culture conditions. For calci-
ummeasurements, cells were plated on glass coverslips at a concen-
tration of 5 × 105 cells/coverslip.
2.4. Dye uptake assay
Unless otherwise speciﬁed, cells were kept at 37 °C for 5min in a salt
solution containing, in mM: 145 NaCl, 5 KCl, 1 MgCl2, 1 mM CaCl2, and
10 Na-HEPES, pH 7.4 (normal extracellular solution) and then for
5min in the presence of 5mMATP or an inhibitor of the AAmetabolism
at the indicated concentrations before the addition of a ﬂuorescent
cell-impermeant dye. The dyes were used in the following concentra-
tions for ﬂow cytometry (2.5 μM EB, 2.5 μM YO-PRO-1, 5 μM PI, 1 μM
TOPRO-3, 1 μM TOPRO-3, 10 μM SR-B, 2.5 μM CF) or ﬂuorescence mi-
croscopy (10 μM EB, 2.5 μM YO-PRO-1, 3 mM SR-B, 5 mM CF, or 3 mM
LY). The cells were analyzed either by ﬂuorescent microscopy or by
ﬂow cytometry, as described below [14,71].
Fluorescence microscopy was performed using an Axiovert 100 mi-
croscope (Karl Zeiss, Oberkochen, Germany) equipped with an HBO
lamp, an Olympus digital camera (Olympus American Inc., PA, USA)
and Image-pro plus v 6.2 software (Media Cybernetics, Inc. Bethesda,
MD, USA). In all ﬂuorescence microscopy observations, cells were also
observed using a clear ﬁeld illumination and at least 50 macrophages
were present in each microscope ﬁeld studied.
Dye uptake was also measured in a ﬂow cytometer (FACSCalibur
cytometer, Becton, Dickinson and Co., Franklin Lakes, NJ, USA). In brief,
freshly isolated macrophages (106/mL) were prepared as described
above and the intensity of dye uptake was immediately determined
using an excitation wavelength of 488 nm (633 nm for TOTO-3) and
an emission wavelength of 590 or 670 nm. At least 5000 data points
were collected for each sample. The results were analyzed using the
WinMDI program (Multiple Document Interface Flow Cytometry
1969H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–1977Application, version 2.8, by Joseph Trotter, The Scripps Research Insti-
tute, La Jolla, CA, USA).
2.5. Induction and analysis of cell death
Suspensions of freshly-isolated intraperitoneal cells (2 × 105 cells/
200 μL) or adherent macrophages in culture dishes were pre-
incubated at 37 °C with/without 5 mM ATP or 50 μM NDGA or vehicle
(0.1 or 1%DMSO) for 20min inDMEMmediumcontaining 2 g/L sodium
bicarbonate and buffered with 10 mM Na-HEPES, pH 7.4. After this pe-
riod, cells were gently washed twice with complete medium to remove
the drugs and further incubated for 6 h at 37 °C as previously described
[14,47]. The cells were then centrifuged at 5600 ×g for 1min, the super-
natant was collected for measurement of LDH content (see below) and
the pellet was used for the determination of apoptosis as described [28].
In brief, the cells were gently suspended in 250 μL of a lysing buffer that
preserved the nuclei for the determination of DNA content (50 μg/mL
ethidiumbromide, 0.1% of sodium citrate, 0.1% Triton-X 100). The nuclei
were then analyzed by ﬂow cytometry (FACSCalibur, Becton Dickinson,
Mountain View, CA, USA) and the degree of apoptosis was quantiﬁed by
counting the number of hypodiploid events. At least 5000 events
were collected per sample and normalized values were calculated by
subtracting the spontaneous apoptosis obtained in the controls (ab-
sence of any other drugs) from all experimental values and taking the
% of the number of hypodiploid events induced by 5 mM ATP as 100%.
Cell lysis (necrosis) was determined by measuring lactate dehydro-
genase (LDH) enzymatic activity in the supernatants collected as above,
using a commercially available colorimetric assay kit according to the
maker's instructions (Doles, Goiania, GO, Brazil) [67]. Control lyses
were obtained by using supernatants of untreated cells (0%) and cells
treated with 0.1% Triton-X 100 (100%). Each reading was subtracted
from the reading obtained in medium containing drugs without cells
in order to avoid any interference of the drugs with the reagents in
the LDH detection kit.
2.6. Intracellular calcium measurements
Macrophages were plated on glass coverslips for 3–5 days and load-
ed with 5 μM Fura-2AM at 37 °C in complete culture medium contain-
ing 2.5 mM probenecid. The cells were then washed twice and
accommodated in a chamber whose base was formed by the coverslip
containing the cells. The cells were maintained at 37 °C in the normal
salt solution described above or in a Ca2+-free solution in which
1 mM EGTA was substituted by 1 mM CaCl2. This solution was heated
to reach 37 °C in the perfusion chamber. Cytoplasmic calcium concen-
trations of groups of 20–40 cells were monitored continuously with
the use of a ﬂuorescence imaging spectroﬂuorimeter (Easy Ratio Pro
equipped with a DeltaRAMX Illuminator, an Olympus IX71 microscope,
a QuantEM 5125C camera and the ImagrePro Plus V 6.3 software; PTI
Photon Technology International, Princeton, NJ). Fura-2 was excited al-
ternately at 340 and 380 nm, and the emission at 510nmwasmeasured.
The ratio measurement, which is proportional to the cytoplasmic calci-
um concentration, was determined every 100 ms. ATP application was
performed by gently removing half the volume of the incubation cham-
ber (500 μL) and adding back the same volume containing the drug at a
2× concentrationwith amanual pipette. Maximum andminimum ﬂuo-
rescence values were obtained by adding ionomycin (20 μM) and EGTA
(20 mM) sequentially at the end of each experiment.
2.7. Measurements of ATP
The extracellular concentration of ATP frommacrophages wasmea-
sured by luminometry, using ﬁreﬂy luciferin-luciferase, which catalyzes
the oxidation of luciferin in the presence of ATP to produce light [76].
For real-time luminometry, glass coverslips containing 2 × 105 macro-
phages, plated as described above, were mounted in the chamber of asingle-channel luminometer as previously described [56]. Before the ex-
periments, cells were bathed in a 300 mosM solution containing (in
mM): 137 NaCl, 2.7 KCl, 4.72 Na2HPO4, 1.50 KH2PO4, 1.32 CaCl2, 1.91
MgSO4, 5 glucose, 0.5% bovine serum albumin, pH 7.4 and kept 20 ºC.
After that, 100 μl of medium containing 1% BSA, 195 μM of luciferin,
12 nM of luciferase and 97.5 μg/ml of Co-A were added a few minutes
before a stimulus. The ﬁnal volume was 100 μL. Alternatively, macro-
phages were plated in 48-well plates and washed twice in the solution
described above immediately before the experiments. Luciferin, CoA
and luciferase were then added as above in a ﬁnal volume of 100 μL
and kept at room temperature. The stimuli were then added into the
bathing solution, gently mixed and luminescence intensity was mea-
sured using an Espectra Max model M5e microplate reader (Molecular
Devices) registering luminescence intensity 1 min post-stimulus. Cells
were stimulated with 50 μMNDGA, MK886 10 μM, equivalent amounts
of DMSO (0.1%), or no additions. The concentrations of ATP in the bath-
ing solution were obtained from calibration curves increasing the ATP
concentrations from 16 to 150 nM, sequentially added to the assay me-
dium from a stock solution of ATP dissolved in the above mentioned
medium. In one set of experiments, the greenﬂuorescence ofmepacrine
was used as an indicator of intracellular ATP content [10,46]. In these
experiments, mepacrine (10 or 100 μM)was added to the bathing solu-
tion 20 min before the addition of the stimuli.
2.8. Data analysis
Unless otherwise speciﬁed, each experiment was performed at
least three times in triplicates and data in bar graphics represent
the mean % ± SEM. Data were analyzed using GraphPad InsTat soft-
ware (GraphPad Software Inc., version 4.0). Values are presented as
mean ± s.d. Differences between experimental groups were evalu-
ated by the two-tailed unpaired Student's t test. A *p value b 0.05,
**p value b 0.01 and ***p b 0.001 were considered statistically
signiﬁcant.
3. Results
3.1. NDGA induces the uptake of organic cations by macrophages
ATPe induces apoptosis and the uptake of large organic molecules
such as Lucifer yellow and ethidium by macrophages, two phenomena
that involve the activation of P2X7 receptors. We have previously
shown that inhibitors of AA-5-LO pathway prevent ATPe-induced apo-
ptosis [14], but the effect of these inhibitors on the uptake of organic
molecules was not investigated. Therefore, our ﬁrst experimentwas de-
signed to investigate the effects the inhibitors of the AA-5-LO pathway
on the uptake of ethidium, a DNA-binding cationic dye that has been
widely used to investigate P2X7 activation. To our surprise we observed
that treating macrophages with 50 μM NDGA at 37 °C for 10 min, the
standard condition used to test the effect of ATPe, induced the uptake
of ethidium at similar or higher levels than the uptake obtained by
exposing the cells to 5mMATP (Fig. 1). The uptake of ethidiumwas ob-
served in freshly isolated cells (Fig. 1A–B) and in adherentmacrophages
in the culture dish (Fig. 1C). When compared to dye uptake induced by
ATP, the uptake of ethidium induced by NDGA was more intense, as
characterized by a more homogeneous distribution in the population
and a higher mean ﬂuorescence per cell (Fig. 1). As in the case of
ATPe-induced uptake, the localization of the dye in the nuclei is an in-
dicative of a transport mechanism that includes a cytoplasmic soluble
phase. The dye uptake is abrogated at low temperatures (Fig. 1C) and
has an EC50 of approximately 30 μM (Fig. 1D). The fast NDGA-induced
ethidium uptake is not an indirect consequence of cell death since, in
agreement with our previously published data [14], and contrary to
ATPe, it does not induce neither apoptosis nor necrosis in macrophages
(Fig. 1E–F). Of note, we also observed that the effect of NDGA and
MK886 (see below) is inhibited in the presence of fetal bovine serum
Fig. 1.NDGA induces the uptake of organic cations but not cell death inmacrophages. Unless otherwise speciﬁed, all experiments were performed using 5mMATP and 50 μMNDGA.Dye
uptake: freshly isolated (A, B, D) and adherentmacrophages (C) were incubated for 10min in normal salt solution containing or not NDGA or ATP and ethidiumbromide. Dye uptakewas
monitored byﬂowcytometry (A, B, D) orﬂuorescentmicroscopy (C). (A)Dye uptake in the absence of drugs (gray line) and in the presence ofNDGA (dark line). (B)Dye uptake induced by
ATP (red line) and by ATP plusNDGA (dark line). (C)Dye uptakemeasured byﬂuorescentmicroscopy at 0 °C (left panels) and at 37 °C (right panels). (D)Dye uptake obtained by exposing
cells to 0–100 μMNDGA. Cell death: apoptosis (E) and necrosis (F) were determined in adherent macrophages 6 h after exposure to ATP or NDGA for 20 min in normal salt solution. All
experiments (except in the left panels of (C)) were performed at 37 °C. In (F) n = 2. **p b 0.01; ***p b 0.001. Bar in (C): 100 μm.
1970 H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–1977(Supplementary data).We therefore used only salt solutions to perform
our dye-uptake experiments
3.2. Inhibitors of the 5-LO pathway induce the uptake of organic cations by
macrophages
We next investigated whether other inhibitors of AA pathways, pre-
viously tested for the inhibition of apoptosis [14], also trigger the same
ethidiumuptake phenomenon.We found that the inhibitors of the 5-LO
pathway MK886, Zileuton, and AA-861 that inhibit ATP-inducedapoptosis [14] also induce the uptake of ethidium (Fig. 2). However,
mepacrine, a generic PLA2 inhibitor, and BEL, an iPLA2 inhibitor, drugs
that inhibit some of the enzymes that produce the AA used by the
5-LO anddonot inhibit ATP-induced apoptosis [14], aswell as the inhib-
itors of the Cox pathway ASA and NS-398, that also had no effect on
ATP-induced apoptosis [14], did not induce any signiﬁcant dye uptake
under our experimental conditions (Fig. 2).
The above results suggested that a selective inhibition of 5-LO en-
zymes is the triggering step to induce the dye uptake phenomenon.
However, transport phenomena induced by NDGA, MK886 and ATP
Fig. 2. Inhibitors of the 5-LO pathway induce the uptake or organic cations bymacrophages. Freshly isolatedmacrophages (white bars) and adherentmacrophages (insert)were incubated
for 10min at 37 °C in normal salt solution containing or not ATP and several inhibitors of AAmetabolism at the indicated concentrations, in the presence of ethidium bromide. **p b 0.01
and ***p b 0.001. Bar in the insert: 100 μm.
1971H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–1977are not signiﬁcantly changed in macrophages derived from 5-LO deﬁ-
cient mice (Fig. 3), suggesting that these inhibitors may have another
common target.3.3. The dye-uptake mechanism is selective to cations and independent of
P2X7 receptors
The fast uptake of ethidium by inhibitors of the 5-LO pathway in
macrophages resembles the P2X7-associated “membrane perme-
abilization”, a phenomenon characterized by a fast uptake of organic
cations and anions limited to a Mr of up to 800–900 Da [75]. We have
previously shown this to be a more complex phenomenon involving
at least two distinct pathways: one for anions and another for cations
[71]. We next performed a series of experiments to compare the two
phenomena using a panel of cationic and anionic dyes. We showed
that, while ATP can induce the uptake of the anionic dyes (Mr for the
free ion in Da) CF (376) and LY (443), the cation-containing dye SR-B
(559), the DNA-binding dyes ethidium (314), and TOPRO-3 (417)Fig. 3.Dye uptake inmacrophages from5-LO−/−mice. Freshly isolatedmacrophageswere
obtained fromWT (black bars) and 5-LO deﬁcient (white bars) mice and were incubated
for 10 min at 37 °C in normal salt solution containing or not 5 mM ATP, 50 μM NDGA or
10 μMMK886 in the presence of ethidium bromide. *p b 0.05 and ***p b 0.001.(Fig. 4A–B), propidium (418), and YO-PRO-1 (375) (data not shown),
NDGA induce the uptake of all cationic dyes tested, but did not induce
the uptake of the anions LY(443) and CF (376) (Fig. 4A–B). In addition,
TOTO-3 (847), the DNA-binding cation with the larger Mr tested, was
taken up by NDGA-treated cells only (Fig. 4A). Besides the selectivity
differences between ATP-induced and LO inhibitor-induced dye uptake
mechanisms, we also showed that NDGA can induce ethidium uptake
even in macrophages derived from animals deﬁcient for the P2X7
gene (Fig. 4C), while ATP induced no signiﬁcant effect, as expected [73].
The charge selectivity of this new transport mechanism did not
allow us to achieve our initial goal – to investigate the effect the inhibi-
tors AA-5-LO pathway reported to prevent ATPe-induced apoptosis, on
the ATPe-induced “permeabilization” – using cationic dyes. We there-
fore investigated the effect of these inhibitors on ATPe-induced uptake
of the anionic dye CF. MK886 (Fig. 4D) and NDGA (data not shown)
had no inhibitory effect on ATPe-induced CF uptake, data that suggest
that P2X7 receptors are not blocked by inhibitors of AA-5-LO pathway.
3.4. Involvement of ATP release induced inhibitors of the AA-5-LO pathway
The above experiments indicate that the uptake of cationic organic
dyes requires neither P2X7 receptors nor active 5-LO enzymes. We
then looked for alternative mechanisms involving the 5-LO inhibitors
used here. During the course of the experiments aimed to investigate
the effect ofmepacrine on the uptake of cationic dyes (Fig. 2), one casual
observation called our attention to the possibility that 5-LO inhibitors
may induce macrophages to release ATP. We noticed that the intensity
of its typical greenﬂuorescence, frequently used as an indicator of cellu-
lar ATP content [10], displayed a strong decrease after addition of NDGA
(Fig. 5A). This observation was consistent with a previous report show-
ing that NDGA could induce the depletion of ATP in a human hepatoma
cell line [5]. However, as mepacrine may also concentrate in any acidic
organelles [46], we next used the more speciﬁc and quantitative
luciferin-luciferase luminometry assays and showed that NDGA and
MK886 induced a signiﬁcant increase in extracellular ATP concentration
(Fig. 5B and C). The extracellular ATP content showed a rapid increment
Fig. 4. Dye-uptake mechanism is selective to cations and independent of P2X7. Freshly isolated (A, C) and adherentmacrophages (B, D)were incubated for 10min in normal salt solution
containing or not 50 μMNDGA, 10 μMMK886 or 5mMATP and different cationic (EB, SR-B, TOPRO-3, TOTO-3) and anionic dyes (CF, LY) as indicated. Dye uptake wasmonitored by ﬂow
cytometry (A, C) or ﬂuorescentmicroscopy (B, D). (A) Dye uptake in the absence of drugs (white bars), in the presence of ATP (black bars), and NDGA (gray bars). (B) Uptake of ethidium
(left panels) and Lucifer yellow (right panels) induced by ATP or NDGA as indicated. (C) Ethidium uptake by freshly isolated macrophages obtained fromWT (black bars) and P2X7-
deﬁcient (white bars). (D) Uptake of CF induced by ATP (upper right), MK886 (lower felt) or both (lower right). The control, in the absence of any inhibitors is shown in the upper left
panel. **p b 0.01 and ***p b 0.001. Bar in (B) and (D): 100 μm.
1972 H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–1977during the ﬁrst 1–2 min after the stimulus and its concentration de-
creased smoothly during the next 20–30 min. The release of ATP was
blocked by brefeldin A (Fig. 5C), suggesting the involvement of an
exocytic process. We next showed that the addition of apyrase at a con-
centration that completely abrogates the raise in extracellular ATP con-
centration (data not show) signiﬁcantly decreased the dye uptake
phenomenon induced by either NDGA or MK886 (Fig. 5D), suggesting
the involvement of a paracrine effect ATP in triggering the cation
transport.
3.5. Inﬂux of calcium is not involved in dye uptake induced by 5-LO
inhibitors
The uptake of cationic dyes and the release of ATP could involve the
formation of large non-selective cation channels or the activation ofother transport mechanisms. We approached this question by measur-
ing the free intracellular Ca2+ concentration ([Ca2+]i) and Ca2+ inﬂux
in Fura-2 loaded macrophages. We showed that the pathway for selec-
tive uptake of cationic dyes does not necessarily involve the opening of a
non-selective cation channels since NDGA, but not MK886, induced a
sustained increase of [Ca2+]i at the same doses that induced dye uptake
(Fig. 6A–D). This increase in [Ca2+]i is dependent on the inﬂux of Ca2+
from the extracellularmedium since it is absentwhen cells are placed in
Ca2+-free salt solution (Fig. 6E) and is maintained after addition of
thapsigargin (1 μM), an inhibitor of the endoplasmic reticulum Ca+2
pump that depletes the intracellular Ca2+ store [80] (data not shown).
In addition, we also showed that dye uptake does not require the pres-
ence of Ca2+ ions in the extracellular medium or a rise in [Ca2+]i since
ethidium uptake induced by both NDGA and MK886 is maintained
also in Ca2+-free extracellular solution (Fig. 6F).
Fig. 5. Inhibitors of the 5-LO pathway induce ATP release and ATP-dependent cation uptake. (A) Mepacrine and ethidium bromide ﬂuorescence in the presence (right panel) or absence
(left panel) of NDGA. Adherent macrophages were incubated with normal salt solution for 20 min with 100 μMmepacrine before the addition of 50 μMNDGA for 10 min. Ethidium bro-
mide (10 μM)was then added for 5min. Cells were kept at 37 °C during the experimental procedure. The emission ﬁlter allowed the simultaneous visualization ofmepacrineﬂuorescence
(green) and ethidium (orange). (B) Time course of ATP release measured by luciferin-luciferase luminometry. A coverslip with adherent macrophages was placed in the luminometer
chamber at 20 °C and ATP release wasmonitored for 10min after the addition of NDGA 50 μM (arrow). (C) Extracellular ATP content measured by luciferin-luciferase luminometry.Mac-
rophageswere plated in a 48well plate and ATP concentrationsweremeasured 1min after the addition of NDGA (50 μM)orMK886 (10 μM) in the presence or not of brefeldinA (BFA 100
nM). Experimentswere performed at room temperature. (D) Flow cytometry analysis of ethidiumuptake by freshly isolatedmacrophages in the presence or not of NDGA (50 μM),MK886
(10 μM), or apyrase (2 units). In (C) and (D) DMSO (1%) was used as solvent control. The concentrations of ATP in (B) and (C)were calculated under the same experimental conditions, in
parallel experiments using a calibration curve as described in Section 2. At least three independent experiments were performed in each case. **p b 0.01 and ***p b 0.001.
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Many channels and other transport mechanisms are present inmac-
rophage membranes and the study of the effects of anti-inﬂammatory
drugs in these transporters may help to understand the action mecha-
nisms of these drugs and ultimately help to improve their design thera-
peutic and use. The experiments described in this work were initially
planned to investigate the effects of several inhibitors of the AA-
pathways on the ATPe-induced, P2X7-mediated dye uptake, usually
called “permeabilization”, of macrophages [60,74]. The focus on this
pathway came from our previous results showing that ATPe-induced
apoptosis, but not necrosis, is blocked by the inhibitors of the 5-LOpath-
way: NDGA,MK886, Zileuton, andAA-861. ATPe-induced apoptosiswas
also blocked by mepacrine, a general inhibitor of phospholipase A2
(PLA2) and by BEL, a selective inhibitor of calcium-independent PLA2
(iPLA2). The inhibitors of the AA-cyclooxygenase pathway ASA and
NS-398 had no effect [14]. It seemed reasonable to ask whether the
blockade of apoptosis could be a consequence of blocking the P2X7-
associated phenomena.
The surprising observation that inhibitors of the 5-LO pathway acti-
vate the uptake of cations interfered with our ability to answer that
question but unveiled two yet undescribed transport phenomena pres-
ent in macrophages – the uptake or organic cations and the release of
ATP – and opened new possibilities to understand the action mecha-
nism of some anti-inﬂammatory drugs. In this work, we describe
some of the basic properties of these transport mechanisms.
We initially showed that NDGA, MK886 and other inhibitors of the
AA-LO pathway could also induce the uptake of organic dyes.Mepacrine
and BEL, which inhibit ATP-induced apoptosis, did not induce signiﬁ-
cant dye uptake under the same experimental conditions. This set of
data suggested that inhibition of P2X7-induced apoptosis and theinduction of this new organic cation uptake mechanism are unrelated
phenomena.
Our original observation used NDGA, an inhibitor of AA-LO metabo-
lism [1,70] and a potent antioxidant [87]. This drug has been proposed
in a large number of medical applications [54] and a number of effects
have been reported such as the blockade of protein transport from the
endoplasmic reticulum to the Golgi complex [79], the redistribution of
Golgi proteins into the endoplasmic reticulum [29], the modulation of
free intracellular calcium concentration in different cells types [13,83],
the inhibition of cytokine secretion as well as the endocytic uptake of
antigens in human dendritic cells [63], the induction of apoptosis [55,
78], the regulation of macrophage proliferation [65] and anti-tumor ac-
tivity in a range of cell lines, including glioma cells, multiple myeloma
cells, prostate cancer cells and human breast cells [38,57,66,86].
Then there is a possibility that either a lipoxygenase-related or
-unrelated mechanism is involved in the modulation of one or more
transmembrane transport mechanisms in macrophages.
In order to better understand the intracellular pathway involved in
the NDGA-induced phenomenon, we used a number of more selective
inhibitors of the AA metabolisms. We showed that MK886, an inhibitor
of 5-lipoxygenase-activating protein (FLAP), considered a more speciﬁc
inhibitor of the AA-5-LO pathway [69], and the selective inhibitors of
5-LO, Zileuton and AA-861 [36,68] also induced the uptake of organic
cations. The inhibitors of the Cox pathway ASA and NS398, and the in-
hibitors of PLA2 mepacrine and BEL induced no dye uptake. These re-
sults strongly indicate that the uptake of cationic dyes here described
for macrophages is selectively triggered by inhibitors of 5-LO pathway
of the AA metabolism.
In addition, we also notice that the phenomenon described here
seems to be unrelated with the anti-apoptotic effect of the inhibitors
used since, although the inhibitors of PLA2 mepacrine and BEL inhibit
Fig. 6. Inﬂux of Ca2+ is not involved in dye uptake induced by 5-LO inhibitors. Free intracellular Ca2+ concentration [Ca2+]i (A-E) and dye uptake (F) of adherent and freshly isolatedmac-
rophages respectively. [Ca2+]i measurement: Cells were loaded with Fura-2 as described in Section 2 and [Ca2+]i was monitored in arbitrary units as F340/380 ratio. Experiments were
performed at 37 °C in normal salt solution or in a Ca2+-free solution containing 1 mM EGTA, as indicated. (A) Variations [Ca2+]i induced by 50 μMNDGA (ﬁrst arrow), 20 μM ionomycin
(second arrow) and 20mMEGTA (third arrow) in normal salt solution (black line) or in Ca2+-free solution (gray line). (B) Variations [Ca2+]i induced by10 μMMK886 (ﬁrst arrow), 20 μM
ionomycin (second arrow) and 20 mM EGTA (third arrow) in normal salt solution. (C-E) Data represent the mean % ± SEM of [Ca2+]i measured 5 min after addition of: (C) 1% DMSO,
10 μMMK886, or 50 μM NDGA in normal salt solution; (D) 1% DMSO or 5–100 μM NDGA in normal salt solution; (E) 1% DMSO or 50 μM NDGA in normal salt solution or 50 μM NDGA
in Ca2+-free salt solution. Dye uptake: Macrophages were incubated for 10 min at 37 °C in normal salt solution (black bars) or in Ca2+-free solution (white bars) or not 5 mM ATP,
50 μM NDGA or 10 μMMK886 in the presence of ethidium bromide. Dye uptake was measured by ﬂow cytometry. *p b 0.05 and ***p b 0.001.
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the latter induced the dye uptake phenomenon.
The mechanism of action of the inhibitors of the 5-LO pathway
remains unclear.We showed that NDGA- andMK886-induced ethidium
uptake is not signiﬁcantly changed in macrophages derived from 5-
LO deﬁcient mice (Fig. 3). These data suggest that other 5-LO-
independent mechanism may also participate in the triggering of the
cation-uptake mechanism. These inhibitors have different structures
and mechanism of action, affecting different targets of the AA metabo-
lism [59,61]. Nonetheless, several reports indicate that some of them
may have other common targets. Examples are anti-oxidant activityby NDGA, Zileuton, AA861 and MK886 [19,59], and the 5-LO-
independent block of the divalent cation channel TRPM7 by NDGA,
AA861, and MK886, but not by Zieluton [12].
Furthermore, it has been described that MK886 and NDGAmediates
mitochondrial dysfunction with possible consequences on the intracel-
lular ATP content [5,7,34]. This is especially interesting as we found that
NDGA andMK886 induce a fast release of ATP bymacrophages. Togeth-
er, these twoATP-related effectsmay cause a signiﬁcant impact onmac-
rophage physiology and response.
Nevertheless, there is a possibility that the phenomena described in
ourworkmay result from a double action of the inhibitors: the blockade
1975H.A. da Silva-Souza et al. / Biochimica et Biophysica Acta 1838 (2014) 1967–1977of the 5-LO pathway (intrinsically provided when using macrophages
derived from 5-LO-deﬁcient mice) and a second 5-LO-independent tar-
get. New experiments are required to clarify these possibilities.
After studying several inhibitors of the AA-5-LO pathway, we pro-
ceed with the phenomenological characterization of the dye uptake
phenomenon induced by MK886 and NDGA.
We ﬁrst notice that NDGA induces a signiﬁcant rise in [Ca2+]i inmac-
rophages (Fig. 6). This Ca2+ signaling requires the presence of Ca2+ in the
extracellular medium, and it is not inhibited by thapsigargin, indicating
that it is due to the inﬂux of the ion. However, the Ca2+ inﬂux seems to
be unrelated to the dye-uptake phenomenon described here because it
is absent in the MK886-induced phenomenon. This result suggests that
we are dealing with a transport mechanism that is selective for organic
cations and not with a non-selective large cation channel. Moreover, the
phenomenon requires neither the presence of extracellular Ca2+ nor its
inﬂux, as shown in the dye-uptake experiments performed in Ca2+-free
extracellular solution (Fig. 6).
There is a possibility thatwe are dealingwith two separate phenom-
ena, one for NDGA and another for MK886, but more likely, due to the
pleiotropic effects of NDGA, the inﬂux of Ca2+ induced by this drug re-
sults fromanunrelated phenomenon.More studies are needed to clarify
the mechanism of Ca2+ inﬂux.
Regardless of the nature of the organic cation transport mechanism,
it is clear that it requires a cytoplasmic soluble stage in order for the
DNA-binding dyes to reach the nuclei. The possibility of a large diffu-
sional channel cannot be excluded but it is unlikely due to the absence
of Ca2+ inﬂux in the MK886-induced phenomenon. Interestingly,
NDGA has been reported to disrupt the endocytic pathway in dendritic
cells and this effectwas inhibited by serum [63]. However neither the 5-
lipoxygenase inhibitor Zileuton nor the FLAP inhibitor MK886 had any
effect on this putative dye uptake mechanism [63].
Several lines of evidence indicate that the dye uptake induced by in-
hibitors of the AA-5-LO pathway is not directly related to the ATPe-
induced P2X7-associated dye uptake. It is selective for cations and
does not necessarily involve Ca2+ inﬂux. Moreover, NDGA and
MK886, but not ATP, induce dye uptake in animals deﬁcient for the
P2X7 gene. Moreover, we also showed that the ATPe-induced uptake
of the anionic dye CF, another hallmark of P2X7 activation in macro-
phages, was not inhibited by inhibitors of the 5-LO pathway (Fig. 4D).
Taken together, our results indicate that inhibitors of 5-LO pathway
such as NDGA and MK886 inhibit ATPe-induced apoptosis without
blocking P2X7 receptors. The same inhibitors induce the uptake of or-
ganic cationic dye that does not require the presence of P2X7 receptors.
However, because we and others have shown that the ATPe-induced
P2X7-associated transport mechanism can involve different pathways
for organic cations and anions [11,47,71], we cannot discard the possi-
bilities that both cation-uptake phenomena are somehow related. In
this regard, we should consider a paracrine role of ATP. Our results
showing that apyrase inhibits the dye-uptake phenomenon (Fig. 5D)
corroborates this possibility. A direct involvement of P2X7 receptors
can be discarded by the experiments using P2X7-deﬁcient macro-
phages. In addition, the lack of a signiﬁcant Ca2+ signal induced by
MK886 (Fig. 6) suggests that no Ca2+-mobilizing P2 receptor is being
activated in the process. In keeping with this possibility, apyrase
added in a concentration that completely abrogates the raise in extra-
cellular ATP concentration did not block the Ca2+ signal induced by
NDGA (data not shown). Therefore, we need to consider other possibil-
ities. Macrophages may display several P2 and P1 receptors, as well as
the ecto-nucleotidases CD39 and CD73 that are potential targets to
ATP and its derivatives [2,40,59] and more biophysical and molecular
studies are required to clarify these possibilities.
Inhibitors of the AA-5-LO pathway are increasingly being used in al-
lergic, respiratory, cardiovascular, and anti-tumor therapies [8,59,61,
62]. We hope that the phenomena of uptake of organic cations and re-
lease of ATP described here may help to improve our knowledge of
the action mechanisms of these inhibitors.Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.04.006.
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